trending Market Intelligence /marketintelligence/en/news-insights/trending/JQfhtWWwYN1LjqrNICLjJA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Immunomedics secures patent for investigational cancer treatment

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Immunomedics secures patent for investigational cancer treatment

Immunomedics Inc. secured patent coverage for its IMMU-140 cancer treatment in the U.S.

The protection will last until July 2033 and will cover the use of IMMU-140 in multiple cancer types, including melanoma, kidney or liver.

IMMU-140 is an investigational drug that is currently under development.